Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission
Public ClinicalTrials.gov record NCT00099359. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III Randomized Trial of the Safety and Efficacy of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV-1 Transmission
Study identification
- NCT ID
- NCT00099359
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Enrollment
- 1,735 participants
Conditions and interventions
Conditions
Interventions
- Zidovudine Drug
- Nevirapine (NVP) Drug
- Epivir (3TC) Drug
- Nelfinavir (NFV) Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 2 Days
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2004
- Primary completion
- Jan 31, 2011
- Completion
- Jan 31, 2011
- Last update posted
- Dec 3, 2012
2004 – 2011
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Miller Children's Hospital | Long Beach | California | 90806 | — |
| University of FL | Gainesville | Florida | 32610-0296 | — |
| University of FL-HSC | Jacksonville | Florida | 32209 | — |
| University Medical and Dental School of NJ-Newark Campus | Newark | New Jersey | 07103 | — |
| Texas Childrens Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00099359, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00099359 live on ClinicalTrials.gov.